0
February 20, 2008, Vol 299, No. 7 >
From the Centers for Disease Control and Prevention | February 20, 2008

Recommended Immunization Schedules for Persons Aged 0-18 Years—United States, 2008 FREE

JAMA. 2008;299(7):758-762. doi:10.1001/jama.299.7.758.
Text Size: A A A
Published online
Article
Figures
References
Figures in this Article

MMWR. 2008;57:Q1-Q4

The Advisory Committee on Immunization Practices (ACIP) annually publishes a recommended immunization schedule for persons aged 0-18 years to reflect changes in vaccine formulations and current recommendations for the use of licensed vaccines. Changes to the previous schedule1 are as follows:

  • The pneumococcal conjugate vaccine (PCV) footnote reflects updated recommendations for incompletely vaccinated children aged 24-59 months, including those with underlying medical conditions.2

  • Recommendations for use of the live attenuated influenza vaccine (LAIV) now include healthy children aged as young as 2 years. LAIV should not be administered to children aged <5 years with recurrent wheezing.3 Children aged <9 years who are receiving influenza vaccine for the first time or who were vaccinated for the first time last season, but only received 1 dose, should have 2 doses of vaccine, at least 4 weeks apart. Other updates are included.4

  • For meningococcal vaccines, changes affect certain children aged 2-10 years.5 Vaccinating with meningococcal conjugate vaccine (MCV4) is preferred to meningococcal polysaccharide vaccine (MPSV4) for children at increased risk for meningococcal disease, including children who are traveling to or residents of countries in which the disease is hyperendemic or epidemic, children who have terminal complement component deficiencies, and children who have anatomic or functional asplenia. The catch-up schedule for youths aged 13-18 years has been updated. MPSV4 is an acceptable alternative for short-term (i.e., 3-5 years) protection against meningococcal disease for persons aged 2-18 years.6

  • The tetanus and diphtheria toxoids/tetanus and diphtheria toxoids and acellular pertussis vaccine (Td/Tdap) catch-up schedule for persons aged 7-18 years who received their first dose before age 12 months now indicates that these youths should receive 4 doses, with at least 4 weeks (not 8 weeks) between doses 2 and 3.

  • The catch-up bars for hepatitis B and Haemophilus influenzae type b conjugate vaccine have been deleted on the routine schedule for persons aged 0-6 years. The figure title refers users to the catch-up schedule for patients who fall behind or start late with vaccinations.

The National Childhood Vaccine Injury Act requires that health-care providers provide parents or patients with copies of Vaccine Information Statements before administering each dose of the vaccines listed in the schedule. Additional information is available from state health departments and from CDC at http://www.cdc.gov/vaccines/pubs/vis/default.htm.

Detailed recommendations for using vaccines are available from package inserts, ACIP statements (available at http://www.cdc.gov/vaccines/pubs/acip-list.htm), and the 2006 Red Book.7 Guidance regarding the Vaccine Adverse Event Reporting System form is available at http://www.vaers.hhs.gov or by telephone, 800-822-7967.

Grahic Jump LocationImage not available.

Grahic Jump LocationImage not available.

Grahic Jump LocationImage not available.

The recommended immunization schedules for persons aged 0-18 years and the catch-up immunization schedule for 2008 have been approved by the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, and the American Academy of Family Physicians. The standard MMWR footnote format has been modified for publication of this schedule.

Suggested citation: Centers for Disease Control and Prevention. Recommended immunization schedules for persons aged 0-18 years—United States, 2008. MMWR 2007;56(51&52):Q1–Q4.

REFERENCES

1 +
CDC.  Recommended childhood and adolescent immunization schedule—United States.  MMWR. 2007;55(51&52):Q1-Q4
2 +
CDC.  Revised recommendations of the Advisory Committee on Immunization Practices (ACIP) for the prevention of pneumococcal disease. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at http://www.cdc.gov/vaccines/recs/acip/downloads/min_oct07.pdf
3 +
CDC.  Expansion of use of live attenuated influenza vaccine (FluMist®) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season.  MMWR. 2007;561217-1219
4 +
CDC.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR. 2007;56(No. RR-6) 
5 +
CDC.  Recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease.  MMWR. 2007;561265-1266
6 +
CDC.  Revised recommendations of the Advisory Committee on Immunization Practices (ACIP) to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine.  MMWR Morb Mortal Wkly Rep. 2007;56(31):794-795
PubMed
7 +
American Academy of Pediatrics.  Active and passive immunization. In: Pickering LK, ed. 2006 red book: report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

1 +
CDC.  Recommended childhood and adolescent immunization schedule—United States.  MMWR. 2007;55(51&52):Q1-Q4
2 +
CDC.  Revised recommendations of the Advisory Committee on Immunization Practices (ACIP) for the prevention of pneumococcal disease. Atlanta, GA: US Department of Health and Human Services, CDC; 2007. Available at http://www.cdc.gov/vaccines/recs/acip/downloads/min_oct07.pdf
3 +
CDC.  Expansion of use of live attenuated influenza vaccine (FluMist®) to children aged 2-4 years and other FluMist changes for the 2007-08 influenza season.  MMWR. 2007;561217-1219
4 +
CDC.  Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP).  MMWR. 2007;56(No. RR-6) 
5 +
CDC.  Recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of quadrivalent meningococcal conjugate vaccine (MCV4) in children aged 2-10 years at increased risk for invasive meningococcal disease.  MMWR. 2007;561265-1266
6 +
CDC.  Revised recommendations of the Advisory Committee on Immunization Practices (ACIP) to vaccinate all persons aged 11-18 years with meningococcal conjugate vaccine.  MMWR Morb Mortal Wkly Rep. 2007;56(31):794-795
PubMed
7 +
American Academy of Pediatrics.  Active and passive immunization. In: Pickering LK, ed. 2006 red book: report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2006

Letters

Submit a Letter
CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Clear Answers | Save For Later
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general journals
BMJ 2010;341:c5893-c1494.
Submit a Response

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles
Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia.
Vaccine Published online May 13, 2013.;
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C(®)) in infants.
Vaccine Published online May 11, 2013.;
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems